Engineers in Prof. Amin Arababian's laboratory have developed a microfluidics system for ultra high-throughput, low-cost, label-free cell detection in liquid biopsies, fetal cell analysis and other applications.
A team of Stanford engineers has developed an efficient battery that can convert salinity gradient power (a.k.a. “blue energy”) into electricity using low-cost, non-toxic electrode materials.
Summary: Stanford researchers at the Melosh Lab have proposed a non-invasive, high electrode density, high resolution (100 micrometers to 10 nanometers) neural device implantation for electrical stimulation of neural/biological tissues.
Researchers in Prof. Sylvia Plevritis' laboratory have developed an algorithm designed to optimize cancer combination therapy for individual patients by analyzing distinct single-cell responses from heterogeneous tumors.
Stanford researchers have invented a fully water-soluble, orange hydrazine sensor that can robustly quantify the toxin hydrazine in liquids such as drinking water, waste water (treated and untreated), and bodily fluids.
Stanford researchers developed a single plasmid reprogramming system called CoMiP carrying codon optimized sequences of the canonical reprogramming factors (OKSM) and short hairpin RNA against p53.
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
Researchers at Stanford have developed methods to classify and treat MYC-driven hematopoietic cancers. The MYC oncogene drives the proliferation and survival of many hematopoietic cancers. These cancers are highly aggressive and do not respond to conventional chemotherapies.
Stanford researchers have patented the use of a coherent frequency-domain technique in microwave thermoacoustic imaging, which significantly improves signal-to-noise ratio (SNR) and reduces peak-power requirements without sacrificing resolution or other performance metrics.
High-grade serous ovarian cancer (HG-SOC) is the most lethal gynecologic malignancy, in large part because most patients present with late-stage disease and receive the same therapeutic regimen despite significant heterogeneity in disease and clinical response.
Researchers in Dr. Anton Wyss-Coray's lab have identified a new therapeutic avenue for treatment of age-related neurodegenerative diseases. Cerebrovascular changes and inflammation are key features of brain aging and neurodegeneration.
Stanford researchers have developed a novel method for the quantification of person-level network functioning, enabling the diagnosis of depression and suggesting an appropriate treatment.
In the presence of intra-fraction organ motion, target localization uncertainty can hamper the advantage of using highly conformal dose techniques such as intensity modulated radiation therapy (IMRT).